Adenosine-derived non-phosphate antagonists for P2Y1 purinoceptors

Biochemical and Biophysical Research Communications

Volumn 272, Issue 2, 2000, Pages 327-331

  Sak, Katrin ^a   Uri, Asko ^a   Enkvist, Erki ^a   Raidaru, Gerda ^a   Subbi, Juhan ^b   Kelve, Merike ^b   Järv, Jaak ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

Author keywords

Adenosine peptide conjugate; Antagonist; Non phosphate nucleotide analogue; P2Y1 purinoceptor

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DERIVATIVE; INOSITOL PHOSPHATE; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; ASTROCYTOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0034616680     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2775     Document Type: Article

References (21)

1. Harden T. K., Barnard E. A., Boeynaems H.-M., Burnstock G., Dubyak G., Hourani S. M. O., Insel P. A. P2Y receptors. Girdlestone D. The IUPHAR Compendium of Receptor Characterization and Classification. 1998;209-217 Burlington Press, Foxton, Cambridge.
2. Hechler B., Vigne P., Leon C., Breittmayer J. P., Gachet C., Frelin C. ATP derivatives are antagonists of the P2Y1 receptor: Similarities to the platelet ADP receptor. Mol. Pharmacol. 53:1998;727-733.
3. Vigne P., Hechler B., Gachet C., Breittmayer J. P., Frelin C. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Biochem. Biophys. Res. Commun. 256:1999;94-97.
4. Camaioni E., Boyer J. L., Mohanram A., Harden T. K., Jacobson K. A. Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. J. Med. Chem. 41:1998;183-190.
5. Nandanan E., Camaioni E., Jang S. Y., Kim Y. C., Cristalli G., Herdewijn P., Secrist J. A., Tiwari K. N., Mohanram A., Harden T. K., Boyer J. L., Jacobson K. A. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J. Med. Chem. 42:1999;1625-1638.
6. Harden T. K., Lazarowski E. R., Boucher R. C. Release, metabolism and interconversion of adenine and uridine nucleotides: Implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol. Sci. 18:1997;43-46.
7. Bhagwat S. S., Williams M. P2 purine and pyrimidine receptors: Emerging superfamilies of G-protein and ligand-gated ion channels receptors. Eur. J. Med. Chem. 32:1997;183-193.
8. Fischer B. Therapeutic applications of ATP-(P2)-receptors agonists and antagonists. Exp. Opin. Ther. Patents. 9:1999;385-399.
9. Uri A., Järlebark L., von Kügelgen I., Schönberg T., Unden A., Heilbronn E. A new class of compounds, peptide derivatives of adenosine 5′-carboxylic acid, includes inhibitors of ATP receptor-mediated responses. Bioorg. Med. Chem. 2:1994;1099-1105.
10. Järlebark L., Erlandsson M., Uri A., King B. F., Ziganshin A. U., Johansson C., Heilbronn E. Peptidyl conjugates of adenosine 5′-carboxylic acid synthesized and evaluated as ligands for P2 purinoceptors. Biochem. Biophys. Res. Commun. 229:1996;363-369.
11. Pehk T., Uri A. Synthesis and structural characterization of conjugates of adenosine and tetra-aspartate, novel analogs of ATP. Bioorg. Med. Chem. Lett. 7:1997;2159-2164.
12. Saenger W. Principles of Nucleic Acid Structure. 1984;Springer, New York.
13. Altona C., Sundaralingman M. Conformational analysis of the sugar ring in nucleosides and nucleotides. Improved method for the interpretation of proton magnetic resonance coupling constants. J. Am. Chem. Soc. 95:1973;2333-2344.
14. Nair V., Young D. A. Conformational correlation of purine nucleosides by high-field carbon-13 NMR data. Magn. Res. Chem. 25:1987;937-940.
15. Sak K., Kreegipuu A., Järv J. P2Y-receptor-ligand database. Trends Biochem. Sci. 25:2000;35.
16. Boyer J. L., Romero-Avila T., Schachter J. B., Harden T. K. Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol. 50:1996;1323-1329.
17. Prasad R. N., Bariana D. S., Fung A., Savic M., Tietje K. Modification of the 5′ position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5′-(N-substituted)carboxamides. J. Med. Chem. 23:1980;313-319.
18. de Zwart M., Kourounakis A., Kooijman H., Spek A. L., Link R., von Frijtag Drabbe Künzel J. K., Ijzerman A. P. 5′-N-substituted carboxamidoadenosines as agonists for adenosine receptors. J. Med. Chem. 42:1999;1384-1392.
19. Moro S., Guo D., Camaioni D., Boyer J. L., Harden T. K., Jacobson K. A. Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 41:1998;1456-1466.
20. Schachter J. B., Li Q., Boyer J. L., Nicholas R. A., Harden T. K. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118:1996;167-173.
21. Sak K., Järv J. Adenosine triphosphate is full antagonist at human P2Y1 purinoceptors. Neurosci. Lett. 284:2000;179-181.